Cours Isodiol International Inc. Canadian Securities Exchange
Actions
ISOL
CA46500L2003
Produits pharmaceutiques
CA 2018 | 19,14 M 26,09 M 17,33 M | CA 2019 | 22,25 M 30,33 M 20,15 M | Capitalisation | 49,96 M 68,11 M 45,23 M |
---|---|---|---|---|---|
Résultat net 2018 | -36 M -49,08 M -32,6 M | Résultat net 2019 | -126 M -172 M -114 M | VE / CA 2018 | 12,6 x |
Trésorerie nette 2018 | 15,55 M 21,2 M 14,08 M | Dette nette 2019 | 5,22 M 7,12 M 4,73 M | VE / CA 2019 | 2,48 x |
PER 2018 |
-4,94
x | PER 2019 |
-0,37
x | Employés | - |
Rendement 2018 * |
-
| Rendement 2019 |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/02/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Director/Board Member | - | 21/11/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+44,36% | 6,34 Md | |
-13,52% | 4,61 Md | |
+10,85% | 3,39 Md | |
-6,52% | 3,29 Md | |
+51,14% | 2,02 Md | |
-5,22% | 1,73 Md | |
+1,29% | 1,67 Md | |
+57,69% | 1,63 Md | |
-9,67% | 1,59 Md |